William Fry Celebrates Double Win at Managing IP Awards
William Fry wins two Managing IP Awards for excellence in trademark disputes and cross‑border patent litigation.
Laura advises on all aspects of work involving patents, trade marks, copyright, designs and confidential information and has extensive experience in large-scale litigation before the Irish Commercial Court. She is particularly experienced in complex multi-jurisdictional patent disputes and has acted in many of the patent cases that have come before the Irish Court in recent years. Laura also has significant experience in acting for regulators in defending judicial review actions, statutory appeals and other legal challenges.
Laura has particular expertise in the pharmaceutical, biotech and medical device sector from a regulatory, commercial and intellectual property perspective and is head of the Firm’s Life Sciences, MedTech and Healthcare Group. Other areas of expertise include regulatory and other issues in the fields of telecommunications, broadcast media, and advertising and marketing.
Laura has maintained Tier 1/ Gold/ Leading Individual status for Intellectual Property and Life Sciences in all leading directories for many years. She has also been listed as one of Managing IP’s Global Top 250 Women in IP since its inception.
Significant cases include:
- acting for Eli Lilly in Commercial Court proceedings seeking revocation of a Novartis patent and in the defence of infringement proceedings (including a competition law counterclaim against Novartis) with respect to Lilly’s product, Taltz®/ixekizumab for the treatment of psoriasis.
- acting for ViiV Healthcare in Commercial Court patent infringement proceedings against Gilead Sciences in respect of an anti-retroviral HIV treatment (Biktarvy®/Bictegravir) and in the defence of Gilead’s counterclaim for invalidity.
- Acting for Skyscanner in defending Commercial Court proceedings by Ryanair and in a competition law counterclaim against Ryanair
- acting for Genentech in its Commercial Court SPC patent infringement proceedings against Amgen in respect of an anti-VEGF antibody used in the treatment of cancer.
- acting for Eli Lilly Commercial Court in patent revocation proceedings in respect of a patent owned by Eisai Pharmaceuticals relating to the treatment of Alzheimer’s Disease. ;
- acting for Merck Sharpe Dohme (MSD) in the defence of Commercial Court patent infringement proceedings brought by Bristol-Myers Squibb / Ono Pharmaceuticals / Tasuko Honjo relating to anti-PD-1 antibodies in the treatment of cancer and MSD’s product, KEYTRUDA and in MSD’s counterclaim for invalidity
- acting for Boehringer Ingelheim in the defence of two sets of Commercial Court proceedings brought by Teva Pharmaceuticals, seeking the revocation of a patent and a supplementary protection certificate in relation to a respiratory product;
- acting for GSK in Commercial Court patent infringement proceedings against Pfizer in relation to a MenB vaccine and in defence of Pfizer’s counterclaim for invalidity;
- acting for GSK in Commercial Court trade mark infringement and passing off proceedings against Rowex Limited in relation to an asthma inhaler product;
- advising Boston Scientific in the defence of Commercial Court patent infringement proceedings relating to coronary stents brought by OrbusNeich and in a counterclaim for invalidity of the patents at issue;
2026 Legal 500 EMEA
"Colette Brady and Laura Scott have shown an impressive ability to balance deep legal expertise in intellectual property with strong business insight, offering advice and solutions that support both legal credibility and commercial success. I highly recommend them for their exceptional legal services in intellectual property matters."
2026 Chambers Europe
"Laura ticks every box. She is a great communicator with all levels and provides clear, pragmatic and appropriate advice." "Laura Scott brings exceptional rigour and creativity to IP enforcement and brand strategy, with a calm authority that inspires confidence in complex or high-stakes matters." "What truly distinguishes Laura is her accessibility, responsiveness, and ability to translate intricate legal issues into practical, business-focused solutions."
2025 Legal 500 EMEA
"Laura Scott is head and shoulders above her peers at other firms in Dublin; for good reason as she is second to none when it comes to patent litigation in Ireland with superb communication skills, knowledge base and determination to secure the best outcome for her clients." "Laura is my go-to contact on all patent litigation matters. She gives great confidence and reassurance to clients on the matters under her control." "Commercial, knowledgeable and able to explain complicated issues clearly."
2024 Chambers Europe
"Laura Scott's commitment to the client and attention to the client's commercial objectives are remarkable.” “Laura has an incredible wealth of experience.” “Laura has a huge amount of litigation experience and a very long track record. She gives it 100% and is a joy to work with.”
2023 IAM Patent 1000
"Laura Scott is a top-notch practitioner with a brilliant strategic mind. She is extremely hardworking, very creative and fiercely advocates for her clients. She is one of the best patent litigators in Ireland."
Article and Insights
Article and Insights
William Fry Celebrates Double Win at Managing IP Awards
William Fry is proud to announce that the Firm has won two awards at the Managing IP Awards 2025 having won 'Irish Trademark Disputes Firm of the Y...
Article and Insights
European Commission Proposes Critical Medicines Act
Critical Medicines Act - the European Commission's new strategy for preventing drug shortages.
Article and Insights
European Commission withdraws SEP Regulation
On 11 February 2025, the European Commission withdrew proposals for regulating Standard Essential Patents.
Article and Insights
When Life Gives You Lemons: Thatchers Squeezes a Win Against Aldi
In a sweet victory for Thatchers, the Court of Appeal of England & Wales overturned the IPEC's controversial 2024 ruling and found that Aldi took u...
Article and Insights
William Fry Wins Irish Patent Litigation Firm of the Year at the Global IP Awards
William Fry is delighted to have been awarded the prestigious title of Irish Patent Litigation Firm of the Year at the Global IP Awards 2024.
Article and Insights
The Regulatory Landscape for Medical Devices at the Close of 2023
With new laws affecting medical devices on the horizon, we discuss changes to the regulatory landscape.
Article and Insights
Supreme Court Refuses Teva Leave to Appeal Preliminary Injunction Order
The Supreme Court has refused leave to Teva to appeal a preliminary injunction granted to Bristol-Myers Squibb pending the outcome of ongoing revoc...
Article and Insights
Health Information Bill 2023: the Potential to Revolutionise How Healthcare Information is Shared in Ireland
On 22 June, William Fry and the Irish Pharmaceutical Healthcare Association co-hosted a panel discussion on the proposed Health Information Bill 2023.
Article and Insights
Court of Appeal Upholds Preliminary Injunction Granted to Bristol-Myers Squibb
The Court of Appeal has upheld the grant of a preliminary injunction in favour of BMS, preventing the launch of Teva's generic version of Apixaban....